However, other studies have indicated that reduced GPX4 expression in colorectal adenocarcinoma (COAD) diminishes the efficacy of PD-1 blockade, which may be due to GPX4 activating cGAS-STING signaling, thereby inducing the infiltration of immune cells in COAD 18. Here, GPX4 is linked to colorectal adenocarcinoma.